Searched for
PHARMA MARKETING PRACTICES
Forget AI and EVs: Zerodha’s Nikhil Kamath spots next big billion-dollar opportunity hidden in India’s biggest problemNikhil Kamath water business idea: India's rapid growth in water-intensive sectors like agriculture, nuclear energy, pharmaceuticals, and d...- How India can win in a rewired global economyIndia is poised to gain from global supply chain shifts. Strategic neutrality and domestic focus are key. The nation must build robust buff...
- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- Quant Small Cap Fund exits HDFC Bank, Jio Financial Services and 5 other stocks in AprilQuant Small Cap Fund reshuffled its portfolio in April, exiting seven stocks including HDFC Bank and Jio Financial Services while adding ne...
- Over 60% of pharma MSMEs yet to comply with updated manufacturing normsPharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...
- 20 months of bearish markets: One additional letter that tells you which 'cheap' stocks are actually cheapMost investors live by one ratio. That ratio that tells them all they want to know – or should one say all they want to hear? They open a s...
- Hospitals and LIC Housing are the best bottom-up bets right now, says Varun SabooMarkets face a tricky situation with rising crude oil, a weakening rupee, and increasing global interest rates. Varun Saboo advises ignorin...
- Geopolitical tensions keep markets nervous despite strong earnings: Dipan MehtaGeopolitical tensions, particularly the Iran crisis, are overshadowing strong corporate earnings, according to Dipan Mehta. While India Inc...
- Why did the stock market fall today? Sensex tumbles 1,300 pts, Nifty below 23,850. 6 key factorsIndian stock markets experienced a significant downturn on Monday. The Sensex and Nifty saw sharp declines as oil prices surged. Fading hop...
- Drugmakers must report safety data from launch date, not approval date: CDSCOIndia's drug regulator has issued a new directive for pharmaceutical companies. Periodic Safety Update Reports for new drugs must now be su...
- Market has already priced in peace; now comes the earnings reality check: Shridatta BhandwaldarMarkets are pricing in a swift conflict resolution, but elevated energy costs will impact corporate margins in the near term. While earning...
- Govt has eased FDI norms for foreign cos having small Chinese/Hong Kong stake: An explainerIndia has eased Foreign Direct Investment rules for companies with up to ten percent Chinese or Hong Kong shareholding. These firms can now...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- GST 2.0 Inverted duty structure hurts FMCG, Pharma: Expert flags concernsIndian enterprises are navigating challenges posed by the Goods and Services Tax. The inverted duty scenario is particularly affecting FMCG...
- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- Govt orders safety review of popular weight-loss drugs amid rising demandIndian authorities are increasing vigilance on popular weight loss drugs. Indian Pharmacopoeia Commission will now compile reports on adver...
- Need to pull up those pill-pushersHealth issues can lead to financial crises. UCPMP tackles unethical practices like Dolo-650 controversy, CBDT accusations. Requires support...
- Pharma sector marketing practices under government scannerA high-level committee formed under Niti Aayog's VK Paul held a meeting on Friday with the representatives of pharma lobby groups to review...
- Government forms committee to regulate marketing practices of pharma companiesThe panel includes secretary of the department of pharmaceuticals S Aparna, Union health secretary Rajesh Bhushan, and Central Board of Dir...
- Mulling a uniform code of pharma marketing practices: GovtThe minister said there were reports in newspapers that some unethical marketing practices were being followed by certain pharma companies.
Load More
